Related Experiment Video
Updated: Jul 2, 2025

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.2K
Cutaneous Metastasis From Prostate Cancer on Posttherapeutic 177 Lu-Prostate-Specific Membrane Antigen Scan
Mohammad Taghavi1, Reyhane Ahmadi2, Mohsen Qutbi3
1From the Hegmataneh Nuclear Medicine Center.
Clinical Nuclear Medicine
|February 27, 2024
Abstract:
In this note, we aim to present a patient with a known case of prostate cancer with widespread metastasis to the skeleton and liver who has undergone several cycles of chemoradiotherapy. The patient received 2 doses of 177 Lu-prostate-specific membrane antigen therapy, in which several zones of uptake were detected on the thoracic wall compatible with cutaneous metastatic lesions of prostate cancer.

